| Code | 8770E | ||||||||||
| MA number | 59/0013/25-S | ||||||||||
| Product Form: | tbl flm 168 (12x14)x30 mg (blis.Al-PVC) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz d.d., Slovenia | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister Al/PVC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 18.02.2025 |
| Validity: | 18.02.2030 |
| SPC: |
SPC_TIVLEMAQ 10 mg 20 mg 30 mg_tbl flm_01.2025.pdf
|
| PIL: |
PIL_TIVLEMAQ 10 mg 20 mg 30 mg, tbl flm_01.2025.pdf
|
| Safety feature | Yes |
| Data update: | 19.02.2025 |
